{
  "id": "mhgap#risk_safety_13f38bc3",
  "content": "y It should be noted that tamoxifen turned out to y Sodium valproate should not be used in women\nbe highly effective in the systematic review used. and girls of childbearing potential because of the\nHowever, it was only based on two small trials with high risk of birth defects and neurodevelopmental\nvery few participants and it does not have an official disorders in children exposed to sodium valproate in\nindication. Tamoxifen has serious side-effects such utero (see recommendation PSY8.2).\nas uterine malignancy, thromboembolic events and\nResearch gaps\nembryo-fetal toxicity (206).\ny Due to the public health importance of this topic, y Most of the evidence is from HICs. Further research is\nthe strength of recommendation was judged as needed in LMICs.\nstrong despite low-quality evidence. During manic y Further research identifying specific side-effects of\nepisodes, bipolar disorder is a debilitating condition single agents is needed.\nthat may lead to an increased risk of mortality and,\nImplementation considerations\nin turn, not having available treatment can pose\nserious risks to the person. y People living with psychotic disorders should\nbe involved in medicine choice in a supported\nRemarks decision-making process.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety y It should be noted that tamoxifen turned out to y Sodium valproate should not be used in women\nbe highly effective in the systematic review used. and girls of childbearing potential because of the\nHowever, it was only based on two small trials with high risk of birth defects and neurodevelopmental\nvery few participants and it does not have an official disorders in children exposed to sodium valproate in\nindication. Tamoxifen has serious side-effects such utero (see recommendation PSY8.2).\nas uterine malignancy, thromboembolic events and\nResearch gaps\nembryo-fetal toxicity (206).\ny Due to the public health importance of this topic, y Most of the evidence is from HICs. Further research is\nthe strength of recommendation was judged as needed in LMICs.\nstrong despite low-quality evidence. During manic y Further research identifying specific side-effects of\nepisodes, bipolar disorder is a debilitating condition single agents is needed.\nthat may lead to an increased risk of mortality and,\nImplementation considerations\nin turn, not having available treatment can pose\nserious risks to the person. y People living with psychotic disorders should\nbe involved in medicine choice in a supported\nRemarks decision-making process. Y it should be noted that tamoxifen turned out to y sodium valproate should not be used in women\nbe highly effective in the systematic review used. and girls of childbearing potential because of the\nhowever, it was only ..."
}